ARCHIVES

Amgen Agrees to Settle Aranesp Marketing Lawsuit, Reserves $780 Million For Settlement

This article is from The Cancer Letter archive.

Vol. 37 No. 40 | October 28, 2011

Download PDF Visit The Full Archive

Related Articles

House-Senate conferees Decide On $733.5 Million (Plus Training Funds) For NCI In 1976

October 31, 1975

Advisors Approve Program To Link Radiation Oncologists.

June 29, 2001

Study Finds More Deaths On Aranesp Arm In Cancer Anemia Study, No Benefit Seen.

February 2, 2007

ODAC Votes Against Adria’s Chemoprotector, Okays Leustatin

July 3, 1992

Clinical Trials: Institutions Invited By NSABP To Join Raloxifene Trial

July 10, 1998

In Brief: Cancer Program “Greatest Experiment And it Works,” ACS President tells Congress

June 25, 1976